VR headsets tested as chemo comfort tool for breast cancer patients
NCT ID NCT07292727
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a virtual reality headset for 30 minutes during chemotherapy can reduce pain and anxiety in breast cancer patients. Fifty participants will either receive standard care or standard care plus VR. Researchers will measure pain and anxiety levels using standard scales.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Virtual reality (VR) headset
- What this could lead to
- If it works, this could offer a drug-free way to ease pain and anxiety during chemotherapy sessions.
- What could go wrong
- This is a small, early-stage study with only 50 participants. The results may not apply to all patients, and VR might not be effective or could cause discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hanaa Hassanin Shehata
Sohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?